US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NYSE
Aventis New Ads (AVE)
Aventis New Ads (AVE) ニュース

AVE

Aventis (AVE)

Aventis New Ads

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:AVE

日付	受信時刻	ニュースソース	見出し	コード	企業名
2004/10/16	06 : 03	PR Newswire (US)	Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A	NYSE:AVE	Aventis New Ads
2004/10/05	04 : 44	PR Newswire (US)	Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers	NYSE:AVE	Aventis New Ads
2004/09/23	06 : 23	PR Newswire (US)	Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease	NYSE:AVE	Aventis New Ads
2004/09/21	22 : 30	PR Newswire (US)	Aventis Named to List of Top 100 Companies for Working Mothers	NYSE:AVE
2004/09/16	16 : 00	PR Newswire (US)	The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity	NYSE:AVE
2004/09/14	22 : 30	PR Newswire (US)	Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease	NYSE:AVE	Aventis New Ads
2004/08/19	22 : 00	PR Newswire (US)	FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer	NYSE:AVE	Aventis New Ads
2004/08/12	00 : 39	PR Newswire (US)	Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole	NYSE:AVE	Aventis New Ads
2004/08/06	09 : 02	PR Newswire (US)	Ventiv Health Announces Sales and Marketing Agreement with Aventis	NYSE:AVE	Aventis New Ads
2004/08/04	03 : 58	PR Newswire (US)	FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)	NYSE:AVE	Aventis New Ads
2004/07/29	04 : 31	PR Newswire (US)	Aventis Reports Second-Quarter and First-Half Results for 2004	NYSE:AVE	Aventis New Ads
2004/07/28	00 : 29	PR Newswire (US)	Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent	NYSE:AVE
2004/07/07	22 : 00	PR Newswire (US)	New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes	NYSE:AVE
2004/06/23	23 : 50	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers	NYSE:AVE
2004/06/15	00 : 43	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend	NYSE:AVE
2004/06/08	02 : 00	PR Newswire (US)	Two Landmark Studies Show That Taxotere(R) Significantly Improves Survival in Men With Prostate Cancer	NYSE:AVE	Aventis New Ads
2004/06/05	23 : 00	PR Newswire (US)	Investigators Report Taxotere(R) Offers Significant Survival Benefits for Head and Neck Cancer Patients	NYSE:AVE	Aventis New Ads
2004/06/02	04 : 40	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers	NYSE:AVE
2004/05/29	02 : 00	PR Newswire (US)	Genta and Aventis Announce Termination of Genasense(TM) Expanded Access Program in Melanoma	NYSE:AVE	Aventis New Ads
2004/05/27	16 : 00	PR Newswire (US)	Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement	NYSE:AVE
2004/05/27	00 : 05	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004	NYSE:AVE
2004/05/26	22 : 00	PR Newswire (US)	Two Landmark Studies of Taxotere(R) in Prostate Cancer Highlighted in American Society of Clinical Oncology Plenary Session	NYSE:AVE	Aventis New Ads
2004/05/24	02 : 15	PR Newswire (US)	Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients	NYSE:AVE
2004/05/24	02 : 15	PR Newswire (US)	Surveillance Study Finds Newly-Approved Antibiotic KETEK(R) (telithromycin) Tablets 99% Effective In Vitro Against Streptococcus	NYSE:AVE
2004/05/20	04 : 39	PR Newswire (US)	Aventis Receives FDA Approval for Taxotere(R) in Prostate Cancer	NYSE:AVE	Aventis New Ads
2004/05/18	22 : 01	PR Newswire (US)	Aventis Receives Priority Review Designation for the Registrational Application to Support the Use of Taxotere(R) in Women with	NYSE:AVE
2004/05/06	00 : 12	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis	NYSE:AVE
2004/05/04	04 : 52	PR Newswire (US)	FDA Advisory Committee Reviews Genasense(TM) for Use in Advanced Melanoma	NYSE:AVE	Aventis New Ads
2004/05/01	04 : 55	PR Newswire (US)	Aventis Pasteur Statement on New Influenza Immunization Recommendations for Infants, Young Children and Their Close Contacts	NYSE:AVE
2004/04/30	03 : 03	PR Newswire (US)	Aventis Reports First-Quarter Results for 2004	NYSE:AVE

Showing the most relevant articles for your search:NYSE:AVE

US Dollar vs Euro

Bank of America

JP Morgan Chase

Financial Select Sector

Gold vs US Dollar

Energy Select Sector SPDR

US Dollar vs Sterling

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約